SCHEMBL24309366

SCHEMBL24309366

Cc1c(Cl)nc(NS(=O)(=O)c2cnn(C)c2)nc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 2/20 0.38
▸ NLRP3 Q96P20 1/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ PTPN11 Q06124 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ FGFR1 P11362 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ GAA P10253 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309813 0.90 NLRP3 (0.38) NLRP3KMT2ATSHRSMN1; SMN2ALDH1A1
SCHEMBL24309831 0.87 KAT6A (0.41) NLRP3SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL24310058 0.87 GAA (0.38) NLRP3SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL24309501 0.86 MALT1 (0.37) NLRP3SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL24309731 0.85 HTR1A (0.38) NLRP3SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL24309573 0.85 HTR1A (0.38) NLRP3SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL24309266 0.84 NLRP3 (0.41) NLRP3KMT2ATSHRSMN1; SMN2ALDH1A1
SCHEMBL24309435 0.84 PDE10A (0.38) PDE10ANLRP3SMN1; SMN2ALDH1A1HTT
SCHEMBL24309413 0.84 KAT6A (0.35) NLRP3SMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL24309403 0.84 PTPN1 (0.35) NLRP3SMN1; SMN2ALDH1A1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback